Cellebrite publishes Q3 2026 earnings call transcript
CLBT•Cellebrite reported third-quarter ARR of $528.5 million, up 20%, and revenue of $149 million, up 18%, both above guidance. It reaffirmed full-year ARR and revenue guidance and raised its adjusted EBITDA outlook to $163 million-$166 million.
1. Q3 results and outlook
Cellebrite’s November 12 earnings call featured CEO Shiven Ramji, CFO David Barter and Chief Revenue Officer Marcus Jewell. Management reaffirmed full-year ARR guidance of $550 million-$560 million, with greater confidence in the lower end amid uncertain deal timing, and revenue guidance of $553 million-$558 million; it raised adjusted EBITDA guidance to $163 million-$166 million. Genesis reached $2 million in ARR in its first full quarter, and management plans to expand it into an AI-native platform in 2027.




